GCC Oncology/Cancer Drugs Market Poised for considerable CAGR Growth Through 2028 - MarkNtel Advisors

GCC Oncology/Cancer Drugs Market, is projected to grow at a considerable CAGR during the forecast period, i.e., 2023-28. This is due to the rising incidences of patients diagnosed with cancer in the nations like the UAE, Saudi Arabia, Kuwait, etc.,

GCC Oncology/Cancer Drugs Market Statistics:

Study Period- Historical Data: 2018-21

Base Year: 2022

Forecast Period: 2023-28

Market Study Report Coverage:

1. Market Fundamentals: Size, share, Revenue, and historical performance metrics.
2. Emerging Opportunity: Escalating Governments Initiatives to Boost the Market Growth
3. Geographical Analysis: Growth hotspots - the UAE is expected to be a hotspot for the demand for oncology/cancer drugs in the forecast years, owing to the massive surge in the cases of breast cancer among the female population of the country.
4. Competitive Benchmarking: Market leaders vs. emerging players.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Download Report Sample PDF - https://www.marknteladvisors.com/query/request-sample/gcc-oncology-cancer-drugs-market.html

GCC Oncology/Cancer Drugs Market Segmentation Analysis (2023–2028)

The study analyzes significant trends in each segment of GCC Oncology/Cancer Drugs Market report, as well as growth estimates for 2023–2028 at the geographical levels.

As per the Report the market segment bifurcated into:

By Therapy

- Chemotherapy

- Immunotherapy

- Targeted Therapy

- Hormonal Therapy

- Others

Based on Therapy, Targeted Therapy is anticipated to attain the highest CAGR in the forthcoming years. 

By Application

- Breast Cancer

- Lung Cancer

- Kidney Cancer

- Liver cancer

- Ovarian Cancer

- Prostate Cancer

- Skin Cancer

- Pancreatic Cancer

- Colorectal

- Blood Cancer

- Others

Breast cancer is among the leading reasons for the death of women in the region. In UAE, 1,054 new cases of breast cancer were registered in 2018. 

By Country

- Saudi Arabia

- The UAE

- Qatar

- Kuwait

- Bahrain

- Oman

GCC Oncology/Cancer Drugs Market Sector Growth Driver:-

Growing Prevalence of Various Cancer Cases to Uplift the Oncology/Cancer Drugs Market

The GCC nations have been witnessing a massive surge in several types of cancer cases including lung cancer, breast cancer, colorectal cancer, prostate cancer, etc. The prominent factor behind the increasing cases of lung cancer in the GCC nations remains the habit of tobacco smoking among the men population. The smoking prevalence has been subsequently leading to a large number of lung cancer cases mainly in Saudi Arabia, Bahrain, and Oman. For instance, in 2020, around 6% male of Saudi Arabia were diagnosed with lung cancer, as per the World Health Organization. Thus, the growing prevalence of different types of cancers among the GCC population would facilitate the requirement for oncology/cancer drugs in the forthcoming period. 

Access the Complete Report for An In-Depth Analysis - https://www.marknteladvisors.com/research-library/gcc-oncology-cancer-drugs-market.html

GCC Oncology/Cancer Drugs Market Competitive Outlook (2023–2028)

This section discusses the major participants in GCC Oncology/Cancer Drugs Market, with a focus on securing new contracts in developing nations to strengthen their footprint

Competitive Analysis Cover:

• Business Description
• Product Segments
• Strategic Alliances or Partnerships
• Recent Developments
• Financial Details
• Others

List of Major GCC Oncology/Cancer Drugs Market Competitor

• Hoffmann-La Roche Ltd.
• Johnson & Johnson Middle East FZ LLC
• Pfizer International Corporation
• Merck Serono Middle East FZ-Ltd.
• AbbVie Biopharmaceuticals GmbH
• AstraZeneca Gulf FZ LLC
• Bayer Middle East FZE
• Amgen, Inc.
• Astellas MENA/SSA
• Others

The market is highly fragmented, with a mix of global and regional players competing for market share. To Learn More About the Global Trends Impacting the Future of Top 10 Companies in GCC Oncology/Cancer Drugs Market

Click Here to Connect with Our Expertise -   https://www.marknteladvisors.com/query/talk-to-our-consultant/gcc-oncology-cancer-drugs-market.html

Frequently Asking Questions (FAQ’s):

• What specific areas and industries are covered in GCC Oncology/Cancer Drugs Market research report?
• How big is GCC Oncology/Cancer Drugs industry?
• Which companies have the largest GCC Oncology/Cancer DrugsMarket share?
• What opportunities, challenges, and driving forces characterize GCC Oncology/Cancer Drugs sector?

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

5 Reasons Why You Should Choose MarkNtel Advisors for Your Market Research Needs:

• Industry Expertise:Benefit from our extensive industry coverage across 80+ countries and 15 diverse industrial verticals.
• Specialized Team:Our experienced market research professionals deliver detailed and satisfactory reports tailored to your needs.
• Strategic Insights:Gain access to strategic analysis for informed decision-making, including market sizing, trend analysis, and competitive benchmarking.
• Client-Centric Approach:We prioritize understanding and fulfilling the diverse needs of our clients with a focus on emerging industries and geographies.
• Global Presence:With a strong presence in multiple countries, we provide quality research reports to help clients navigate global markets effectively.

About US:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

For Media Inquiries, Please Contact: 

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511 

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India